Samsung Pharm (001360) — Cash Flow Quality Index
Samsung Pharm (001360) has a Cash Flow Quality Index of -0.01x as of June 2025. Operating cash flow of ₩-804.23 Million is below net income of ₩63.57 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Samsung Pharm long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Samsung Pharm Cash Flow Quality Index (2019–2019)
Historical Cash Flow Quality Index for Samsung Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Samsung Pharm (001360) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Samsung Pharm (2019–2019)
Year-by-year earnings quality comparison for Samsung Pharm. For live market cap and the full company financial profile, see 001360 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -0.35x | ₩-2.43 Billion | ₩6.89 Billion | — |